InMed Pharmaceuticals Inc. Common Shares

INMNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
1.56 USD
↘ 0.03 (1.89%)AT CLOSE (11:59 AM EDT)
1.47
↘ 0.09 (6.03%)
POST MARKET (AS OF 07:36 PM EDT)
Post Market
AS OF 07:36 PM EDT
1.47
↘ 0.09 (6.03%)
🔴Market: CLOSED
Open?$1.58
High?$1.66
Low?$1.55
Prev. Close?$1.59
Volume?92.8K
Avg. Volume?3.4M
VWAP?$1.59
Rel. Volume?0.03x
Bid / Ask
Bid?$1.46 × 100
Ask?$1.70 × 100
Spread?$0.24
Midpoint?$1.58
Valuation & Ratios
Market Cap?5.3M
Shares Out?3.3M
Float?2.6M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?0.76
EPS?-$2.57
Dividend?0.00%
Ex-Dividend?N/A

InMed Pharmaceuticals Inc. Common Shares (INM) is currently trading at $1.56. INM shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 4, 2026.

News
Profile
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsCannabis›CBD & Hemp Products
Employees
13
Market Cap
5.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.inmedpharma.com
Listed
2020-11-10
Address
1445-885 WEST GEORGIA ST.
VANCOUVER, A1 V6C 3E8
Phone: (604) 669-7207
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
7
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-19.61Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.02%Low
Short Interest?26.6K
Days to Cover?1.5
Free Float2.6M
Avg Daily Volume18.4K
Settlement Date2026-05-15
Financial Health
Current Ratio?4.92Strong
Quick Ratio?4.92Strong
Cash Ratio?3.68Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
50
S&P
97
0.76CHEAP▾
P/S?
Peers
50
S&P
76
1.62CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.0CHEAP▾
EV/Sales?
S&P
97
0.03CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-123.5%WEAK▾
ROA?
S&P
3
-93.2%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$110.4K
Fundamentals ratios updated end of day
MarketsMoversWatchlist